These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21607915)

  • 1. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case.
    Postorino MC; Bellantoni M; Catalano C; Caridi G; De Rosa M; Seck S; Enia G
    J Nephrol; 2011; 24(4):530-4. PubMed ID: 21607915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient.
    Mirzabeigi M; Farooq U; Baraniak S; Dowdy L; Ciancio G; Vincek V
    J Cutan Pathol; 2006 Oct; 33(10):701-4. PubMed ID: 17026523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil.
    Oliveira RA; Silva LS; Carvalho VP; Coutinho AF; Pinheiro FG; Lima CG; Leandro JE; Silva GB; Daher EF
    Transpl Infect Dis; 2008 Oct; 10(5):364-8. PubMed ID: 18507750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
    Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
    Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management.
    Veroux M; Corona D; Giuffrida G; Cacopardo B; Sinagra N; Tallarita T; Giaquinta A; Zerbo D; Veroux PF
    Transpl Infect Dis; 2010 Oct; 12(5):387-91. PubMed ID: 20534033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis after orthotopic liver transplantation: a rare cause of infection.
    Pereira CM; Oliveira HM; Lopes V; Gandara J; Ferreira S; Daniel J; Miranda HP
    Transpl Infect Dis; 2016 Apr; 18(2):251-4. PubMed ID: 26895697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
    Vigna E; De Vivo A; Gentile M; Morelli R; Lucia E; Mazzone C; Recchia AG; Vianelli N; Morabito F
    Transpl Infect Dis; 2010 Oct; 12(5):428-31. PubMed ID: 20534035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis after kidney transplantation: report of a new case and a review of the literature.
    Bouchekoua M; Trabelsi S; Ben Abdallah T; Khaled S
    Transplant Rev (Orlando); 2014 Jan; 28(1):32-5. PubMed ID: 24321305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.
    Sirvent-von Bueltzingsloewen A; Marty P; Rosenthal E; Delaunay P; Allieri-Rosenthal A; Gratecos N; Cassuto JP
    Bone Marrow Transplant; 2004 Mar; 33(6):667-8. PubMed ID: 14730334
    [No Abstract]   [Full Text] [Related]  

  • 11. Visceral leishmaniasis caused by Leishmania infantum in Thailand.
    Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis among liver transplant recipients: an overview.
    Campos-Varela I; Len O; Castells L; Tallada N; Ribera E; Dopazo C; Vargas V; Gavaldà J; Charco R
    Liver Transpl; 2008 Dec; 14(12):1816-9. PubMed ID: 19025932
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diarrhea due to visceral leishmaniasis in a liver transplant recipient].
    Vargas Acosta AM; Belchí Segura E; Martinez Caselles A; Baños Madrid R; Pons Miñano JA; Parrilla Paricio P
    Gastroenterol Hepatol; 2013 Apr; 36(4):271-3. PubMed ID: 23453560
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative.
    Gómez Campderá F; Berenguer J; Anaya F; Rodriguez M; Valderrábano F
    Am J Nephrol; 1998; 18(2):171. PubMed ID: 9569963
    [No Abstract]   [Full Text] [Related]  

  • 15. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
    Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
    Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
    Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C
    BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.
    Pérez-Jacoiste Asín MA; Carrasco-Antón N; Fernández-Ruiz M; San Juan R; Alonso-Moralejo R; González E; Andrés A; López-Medrano F; Aguado JM
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27768239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of localized cutaneous leishmaniasis in an organ transplant recipient: case report and literature review.
    Zandieh A; Zandieh B; Dastgheib L
    Int J Dermatol; 2013 Jan; 52(1):59-62. PubMed ID: 23278609
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
    J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].
    Rosenthal E; Delaunay P; Jeandel PY; Haas H; Pomares-Estran C; Marty P
    Med Mal Infect; 2009 Oct; 39(10):741-4. PubMed ID: 19783391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.